Research Funding

ASGCT members have collectively engaged in over two decades of the basic, translational, and clinical research that has led to the recent critical clinical advancements in the gene and cell therapy field. A key strategic priority of the Society is to support continued innovation by encouraging federal research funding for gene and cell therapy research. ASGCT will be further engaging with NIH Institutes and Centers to highlight research needs and funding gaps and to advocate for ways to address them. Policy positions have included support of the following:

  • Robust appropriations from Congress to the National Institutes of Health (NIH) for biomedical research in general.

  • Dedicated funding from Congress to the NIH specifically for gene and cell therapy research, such as through continued funding of the Regenerative Medicine Innovation Project.

  • Inclusion of gene and cell therapy research in the priorities of NIH Institutes and Centers in the awarding of research funding.

Committee Involvement

The Government Relations Committee provides oversight and input to ASGCT staff on Society efforts in support of research funding.

Collaborative Efforts

ASGCT is a member of the following alliances:

  •  The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) Coalition
  • Research!America, to amplify our support for federal biomedical research funding







Register for the ASGCT Policy Summit

September 23-24, 2024 | Washington, D.C.

This site uses cookies to offer you a better user experience and to analyze site traffic. By continuing to use this website, you accept our use of cookies.